Here’s Why I Would Avoid Investing In The FTSE 100

Why this Fool isn’t buying the FTSE 100 (INDEXFTSE: UKX) index.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s well-known that many active investors fail to beat their benchmarks, like the FTSE 100 year after year. This trend has led many investors to buy low-cost FTSE 100 index trackers as an alternative to actively managed funds. 

Nevertheless, I believe that many UK investors are making a mistake by investing in the FTSE 100. You see, the FTSE 100 is an international index — it’s estimated that 70% of the FTSE 100’s profits come from outside the UK. 

So, when you buy the FTSE 100 as a whole, you’re placing a bet on international growth. What’ more, the FTSE 100’s top nine constituents account for nearly 40% of the index. 

With this being the case, the FTSE 100 index is hardly the best index to track. Indeed, for a play on UK economic growth the FTSE 250 is a better bet. And to profit from global economic growth, it could be better to track the S&P 500, STOXX 600 and MSCI World indexes. 

Diversification wins 

At its core, the FTSE 100 is an index made up of a few main holdings, including HSBCRoyal Dutch ShellVodafoneBPBritish American Tobacco, and GlaxoSmithKline. Such a concentrated portfolio may suit some investors, but it’s hardly a recipe for growth.   

For example, the FTSE 100 has returned 400% over the past three decades, a compound annual growth rate of around 5.6% per annum excluding dividends. However, over the same period the S&P 500 has returned 1080%, excluding dividends, a compound annual growth rate of 8.8% per annum. 

Similarly, during the past five years the STOXX 600 and MSCI World indexes have both outperformed the FTSE 100 by 22% and 64% respectively.

It’s pretty easy to see why these international indexes have been able to beat the FTSE 100 over the years. The FTSE 100 lacks diversification and as a result, the index is falling behind.

As their names suggest, the S&P 500 and STOXX 600 have 500 and 600 constituents respectively. The constituents are the largest companies in the world with household names such as Coca-ColaJohnson & JohnsonNestleApple and Google featuring in the top ten holdings. 

Further, as the STOXX 600 is designed to represent the 600 largest European companies, many of the index’s top constituents are also included in the FTSE 100. HSBC, Shell and BP are just three of the STOXX 600’s top 10 components. 

If you’re looking for even more diversification, the MSCI World index tracks the share price of more than 1,660 companies. The index has risen by around 7.1% per annum since 1994. 

Three top trackers

Replicating the performance of the STOXX 600, S&P 500 and MSCI World is just as easy as replicating the performance of the FTSE 100 — all you need to do is buy a low-cost tracker. 

There are plenty of low-cost trackers out there, but three of the best are the iShares STOXX Europe 600 UCITS ETF, which has a total expense ratio of 0.20%. The $160bn SPDR S&P 500 ETF Trust, which has a total expense ratio of 0.09%, and the MSCI World ETF, which has a total expense ratio of 0.24%.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has recommended shares in HSBC and GSK, and owns shares in Apple and Google. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young woman holding up three fingers
Investing Articles

3 FTSE 100 shares I think look undervalued heading into May

This trio of FTSE 100 dogs have been moving in the opposite direction from the flagship blue-chip index so far…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

As the Lloyds share price falls while profits rise, is it time to dump?

Investors might be getting cold feet over the Lloyds share price, as a better-than-expected quarter still resulted in a decline.

Read more »

Buffett at the BRK AGM
Investing Articles

Might it make sense to ‘go away’ from the stock market in May?

Drawing on Warren Buffett and Charlie Munger's long-term investing approach, this writer explains why he won't be ignoring the stock…

Read more »

British union jack flag and Parliament house at city of Westminster in the background
Investing Articles

Up 1,000% in 5 years, but the UK government could send Rolls-Royce shares even higher

Rolls-Royce shares have been in the doldrums in the past few weeks. Is the long-term picture still as bright as…

Read more »

Investing Articles

As GSK shares fall 5% on Q1 news, is this a buying opportunity?

GSK reinforced its upbeat guidance for the year ahead in a Q1 update, after an impressive 2025, but the shares…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

Meet the FTSE 250 stock that has left Rolls-Royce, Nvidia and BP in the dust

This FTSE 250 stock has risen more than 900% in the past year, including a 19% jump today. What's behind…

Read more »

Rear view image depicting a senior man in his 70s sitting on a bench leading down to the iconic Seven Sisters cliffs on the coastline of East Sussex, UK. The man is wearing casual clothing - blue denim jeans, a red checked shirt, navy blue gilet. The man is having a rest from hiking and his hiking pole is leaning up against the bench.
Investing Articles

How much is needed in an ISA for an annual income equal to this year’s £12,547 State Pension?

The State Pension is the bedrock for most people's retirement income. Now imagine doubling it, and taking all the extra…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

What next for AstraZeneca shares, after another cracking quarter?

AstraZeneca shares have made storming gains since Pascal Soriot became the boss. The latest outlook suggests it could be far…

Read more »